1. Immunoreactive angiotensin II was measured in cerebrospinal fluid of four normal dogs.
Introduction
In dogs, angiotensinogen is present in cerebrospinal fluid at relatively high concentrations, although canine cerebrospinal fluid is reported not to contain renin (Reid & Ramsay, 1975) . However, immuno reactive angiotensin II has been found in the cerebrospinal fluid of rats (Ganten, Hutchinson, ' Schelling, Ganten & Fischer, 1976) , sheep (Ab raham, Baker, Blaine, Denton & McKinley, 1975) and man (Finkielman, Fischer-Ferraro, Diaz, Goldstein & Nahmod, 1972) . The central effects of both angiotensin II and Des-Asp'-angiotensin II have been considered to play a role in thirst (Fitzsimons, 1971) and to alter blood pressure (Erickson & Fyhrquist, 1976) . Because Des-Asp'-angiotensin II, Des-Asp'-Arg 2 -angiotensin II and Des-Asp'-Arg 2 -Val 3 -angiotensin II cross-react in virtually every radioimmunoassay for angiotensin II published (Ruiz-Maya,. Tiller & Walker, 1974; Stockigt, Shizgal & Ganong, 1971; Oelkers, Diisterdieck & Morton, 1972; Emanuel, Cain & Williams, 1973; Hutchinson, Schelling, Möhring & Ganten, 1976; Mendelsohn, 1976) , an electrophoretic method was used to separate these polypeptides to identify the immunoreactive angio tensin II material present in normal canine cere brospinal fluid and to test for the presence of angiotensinases that may have contributed to the production of any immunoreactive fragments of angiotensin II.
Methods
Clear cerebrospinal fluid was obtained by cisternal puncture from two greyhounds and two mongrel dogs immediately after induction of anaesthesia by intravenous sodium pentobarbitone [Sagatal, 30 mg (121 /miol) /kg]. Samples of cerebrospinal fluid were also obtained from eight mongrel dogs after at least 4h of anaesthesia maintained by continuous intravenous infusion of sodium pentobarbitone [5 mg (20 μτηοΐ) h _1 kg -1 ]. Apart from samples obtained for angiotensinase testing (see below) cerebrospinal fluid was taken into an ice-cold 5% (v/v) solution of angiotensinase inhibitor Γ12-6 mmol (2-5 g) of cr-phenanthroline (Merck) in 2 ml of ethanol, 62-3 mmol (23-2 g) of disodium ethylenedinitrotetra-acetate (Titriplex III, Merck), 1-6 mmol (1 g) of neomycin sulphate and distilled water to a final volume of 500 ml] and was stored at -20°C. Samples for assay were thawed at 4°C.
Immunoreactive angiotensin II-like material was measured by radioimmunoassay (Oster, Hac kenthal & Hepp, 1973) . The antibody was used at a final dilution of 8-4 x 10" 6 (Ka = 7-5 x 10 10 1/mol; high-affinity binding sites were 210-9 μπιοΐ/ΐ). Cross-reactivity of angiotensin I in the angiotensin II radioimmunoassay was less than 0-1%. from the origin. The buffer was Tris/borate (0-065 mol/1), pH 8-87 (Allen & Moore, 1966) . The gels were cut into 1 cm 2 segments and the immuno reactive material was eluted with 1 ml of a Tris/acetate (0-1 mol/1) immunoassay buffer, pH 7-4, with two cycles of freezing to -20° C followed by thawing at 4°C. Portions of each eluate were then assayed for immunoreactive angiotensin II.
To test for angiotensinase activity in cere brospinal fluid collected on ice only, portions were incubated with 125 I-labelled angiotensin II at 37°C for 1 h. Control samples consisted of portions of artificial canine cerebrospinal fluid (Merits, 1940) incubated under identical conditions with 125 Ilabelled angiotensin II. The samples were electro phoresed as above and the radioactivity in the 1 cm 2 segments was measured in an Auto-Gamma scintillation spectrometer (model 5130, Packard Instrument Co., Illinois, U.S.A).
The biologically active material in the canine cerebrospinal fluid was measured in a bilaterally vagotomized, anaesthetized, ganglion-blocked rat pressor bioassay (Peart, 1955) . A competitive antagonistic analogue of angiotensin II, Sar'-Ala 8 -angiotensin II(PI 13, Norwich Pharmacal) was used in the bioassay to identify the pressor material as angiotensin II or Des-Asp'-angiotensin II.
Results
The concentrations of immunoreactive and bio logically active angiotensin II-like material in Table  1 indicate a wide range of values in the four dogs where samples were obtained immediately after induction of anaesthesia. Only these dogs had sufficient material present for the sensitivity of the present methods for analysing angiotensin frag ments. In the eight dogs where samples were obtained 4 h after induction of anaesthesia the concentration of immunoreactive angiotensin II in cerebrospinal fluid was 15-7 ± 3-6 pmol/1 (mean + SEM). Immunoreactive angiotensin I could not be detected in canine cerebrospinal fluid, i.e. less than 10 pmol/1.
From the electrophoretic pattern of the immuno reactive angiotensin II material, the major portion of immunoreactivity had the same mobility as DesAsp'-angiotensin II (Table 2, Fig. 1 ). Recoveries of standards were 89% for Des-Asp'-Arg 2 -Val 3 -angiotensin Π, 98% for Des-Asp'-Arg^angiotensin II, 57% for Des-Asp'-angiotensin II and 65% for angiotensin II.
A small part of the immunoreactive material in the cerebrospinal fluid sample migrated as far as the immunoreactive peak of angiotensin II but there was virtually no immunoreactivity corre sponding to the Des-Asp'-Arg^angiotensin II or Table 2 summarizes data for the relative mobility of the major immunoreactive peak in the four dogs. Although each sample of canine cerebrospinal fluid was run on a polyacrylamide gel with a set of standards at the same pH of 8-87, the resistance of the gels varied and the absolute values for migration varied from run to run. In all four cases the major peak of immunoreactive material in canine cerebrospinal fluid migrated with the same electrophoretic mobility as immunoreactivity due to Des-Asp'-angiotensin II.
The radioactivity of the 125 I in the samples of '"Habelled angiotensin II incubated with canine cerebrospinal fluid and with artificial canine cere brospinal fluid migrated on polyacrylamide gel in exactly the same manner (0·78 relative to the Bromophenol Blue tracking dye as 1-00). Mean recovery of radioactivity in both cases was 99 + 4% (SEM; n = 4). Cerebrospinal fluid showed pressor activity of similar type and duration to angiotensin in the bioassay rat (Fig. 2) . This biological activity of canine cerebrospinal fluid was abolished by Sar'-Ala'-angiotensin II (PI 13, Fig. 2 ) in the same way as were the responses to both angiotensin II and Des-Asp'-angiotensin II. The agonistic activity of Sar'-Ala 8 -angiotensin II was also abolished by the injection of Sar'-Ala'-angiotensin II 10 min earlier.
Des-Asp'-Arg 2 -angiotensin II and Des-Asp'-Arg 2 -Val 3 -angiotensin II did not have pressor activity in the bioassay in the concentration range used (1-20 mmol/1).
The pressor activity of cerebrospinal fluid was linearly related to concentrations of angiotensin IIimmunoreactive material (Fig. 3) . The activity of cerebrospinal fluid was lower than would have been the case had all the material been in the form of molecular angiotensin II. It was about the expected order if all the material had been in the form of Des-Asp'-angiotensin II.
Discussion
Our results suggest that most of the angiotensin IIlike immunoreactivity in normal canine cer ebrospinal fluid is in the form of Des-Asp'-angiotensin II, as shown by both the results of electrophoretic mobility and the relationship bet ween bioassay pressor values and immuno reactivity values. Although the pressor responsive ness of canine cerebrospinal fluid is close to that of Des-Asp'-angiotensin II it is not a 1:1 relationship. There appears to be about 20% more pressor activity than can be accounted for by Des-Asp 1 -angiotensin II. Even though there is a good statistical correlation between the immuno reactivity and the biological activity of canine cerebrospinal fluid it is obviously weighted by the data from dog no. 1 (Table 1) . We cannot explain the variability of immunoreactive angiotensin II in canine cerebrospinal fluid from the four normal dogs. The very low amounts present in the cerebro spinal fluid from the eight dogs anaesthetized for at least 4 h suggests that anaesthesia interferes with the appearance of immunoreactive angiotensin II in cerebrospinal fluid. The full time-course of these changes remains to be studied.
It is unlikely that substances such as catecholamines contribute to the pressor response in the bioassay since the effect was blocked by a specific angiotensin II antagonist. The somewhat greater pressor response of cerebrospinal fluid material than could be accounted for by the DesAsp'-angiotensin II could have been due to small concentrations of angiotensin II or to the high amounts of substrate known to occur in canine cerebrospinal fluid (160 nmol of angiotensin 1/1: Reid & Ramsay, 1975) . Theoretically this may have been acted upon by renin and converting enzyme in the bioassay rat to form biologically active angiotensin, the activity of which would also have been blocked by Sar'-Ala 8 -angiotensin II. However, the small volumes injected are very unlikely to raise the plasma renin substrate con centration of the rat, which is greater than 160 nmol/1.
The immunoreactive angiotensin II present in the cerebrospinal fluid is of extrarenal origin, as it is present in bilaterally nephrectomized animals and [ 3 H] angiotensin has been shown not to penetrate the bloodcerebrospinal fluid barrier (Schelling, Hutchinson, Ganten, Sponer & Ganten, 1976) . As there are no detectable activities of renin-like enzymes (Reid & Ramsay, 1975) or, as shown in the Results section, of angiotensinases in canine cerebrospinal fluid, it is unlikely that Des-Asp'-angiotensin II is formed in cerebrospinal fluid.
The Des-Asp'-angiotensin II in cerebrospinal fluid may be a metabolite excreted from brain tissue by a conventional angiotensin II-forming system, but the finding of biological activity for Des-Asp'-angiotensin II on the subfornical organ (Schlegel & Felix, 1976) raises the interesting possibility that Des-Asp'-angiotensin II may be the biologically active end product of an alternative biosynthetic pathway (Tsai, Peach, Khosla & Bumpus, 1975 ) in brain tissue.
